Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported ...

The founder and former leader of Inhibikase Therapeutics is blazing a new biotech trail in an effort to get a beleaguered ...

First quarter 2025 Prenatal revenue grew 11% year-over-year, while Pharmacogenomics revenue declined by 20% year-over-year due to UnitedHealthcare (UNH) reducing coverage of GeneSight®. MyRisk®testing ...

When asked where the future of the ABL lies following the Aces’ exit, Baseball Australia boss Glenn Williams said “we will continue to work with teams on planning for the ABL for season 25-26”.

SANTA FE, N.M. (AP) — Betsy Arakawa, the concert pianist who was married to actor Gene Hackman, died from hantavirus pulmonary syndrome, according to an autopsy report released Tuesday that said ...

The official cause of death for actor Gene Hackman has been confirmed following his passing at the age of 95. Gene was found deceased at his Santa Fe residence with his wife Betsy Arakawa ...

The final autopsy report for Oscar-winning actor Gene Hackman has been released by the Office of the Medical Investigator in New Mexico, offering new insights into the circumstances surrounding ...

Preity Zinta balances Bollywood glamour and IPL energy, while her husband, Gene Goodenough, maintains a low profile. Based in Los Angeles, Gene is a finance expert with a successful career at ...

A team from the University of Geneva (UNIGE) discovered that a single gene, CLCN2, is involved in these variations. The study, published in Genome Biology, opens new perspectives on the evolution ...

The rock star says one of his favorite things about the home is "on a clear day, being able to see all the way out to the ocean" Gene Simmons Gene Simmons is kissing his Beverly Hills home goodbye!

This inhibitor is designed to specifically target the BCR-ABL gene fusion. It has an Orphan Drug designation and is currently being evaluated in a Phase 1 trial to treat chronic myeloid leukemia ...

In a new study published in Nature titled, “Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learning,” researchers from Massachusetts General Hospital (MGH) and Harvard ...